Notice: This company has been marked as potentially delisted and may not be actively trading. Imago BioSciences (IMGO) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period RA Capital-backed startup raises $100M; UCB sells China businessAugust 28, 2024 | finance.yahoo.comAvidity Biosciences Stock (NASDAQ:RNA), Analyst Ratings, Price Targets, PredictionsMay 5, 2024 | benzinga.comImago Theatre aims to find out if time-traveling Neanderthals have answers to climate changeApril 13, 2024 | msn.comMerck: Better Times Ahead On Approvals And OutlookApril 2, 2024 | seekingalpha.comClarus Lifesciences III, L.P.'s Net WorthFebruary 23, 2024 | benzinga.comAnixa Biosciences Inc ANIXDecember 21, 2023 | morningstar.comHarmony Biosciences shares are trading lower after the company reported Q4 financial results.February 23, 2023 | benzinga.comMerck To Complete Acquisition Of ImagoJanuary 11, 2023 | markets.businessinsider.comMerck Completes Tender Offer to Acquire Imago BioSciences, Inc.January 11, 2023 | finance.yahoo.comTrading was temporarily halted for "IMGO" at 07:01 PM with a stated reason of "News pending."January 11, 2023 | marketbeat.comLooking Into Imago BioSciences's Recent Short InterestJanuary 4, 2023 | msn.comMerck is best performing large U.S. pharma of 2022December 30, 2022 | seekingalpha.comLaura G. Eichorn Sells 3,100 Shares of Imago BioSciences, Inc. (NASDAQ:IMGO) StockImago BioSciences, Inc. (NASDAQ:IMGO - Get Rating) CFO Laura G. Eichorn sold 3,100 shares of Imago BioSciences stock in a transaction that occurred on Tuesday, December 27th. The stock was sold at an average price of $35.93, for a total value of $111,383.00. Following the completion of the sale, the chief financial officer now directly owns 207,737 shares in the company, valued at approximately $7,463,990.41. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.December 29, 2022 | marketbeat.comImago BioSciences, Inc. (NASDAQ:IMGO) Given Average Recommendation of "Hold" by AnalystsShares of Imago BioSciences, Inc. (NASDAQ:IMGO - Get Rating) have received a consensus rating of "Hold" from the seven analysts that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating. The average 1-year price target among analysts that have issDecember 23, 2022 | marketbeat.comImago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in MyelofibrosisDecember 20, 2022 | finance.yahoo.comImago BioSciences, Inc. (NASDAQ:IMGO) Insider Jennifer Peppe Sells 119,422 SharesImago BioSciences, Inc. (NASDAQ:IMGO - Get Rating) insider Jennifer Peppe sold 119,422 shares of the firm's stock in a transaction that occurred on Thursday, December 15th. The shares were sold at an average price of $35.80, for a total transaction of $4,275,307.60. Following the sale, the insider now directly owns 148,809 shares of the company's stock, valued at approximately $5,327,362.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.December 19, 2022 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, USERDecember 13, 2022 | markets.businessinsider.comImago BioSciences, Inc. (NASDAQ:IMGO) Short Interest Down 79.4% in NovemberImago BioSciences, Inc. (NASDAQ:IMGO - Get Rating) was the recipient of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 706,100 shares, a decline of 79.4% from the November 15th total of 3,430,000 shares. Approximately 3.5% of the shares of the company are sold short. Based on an average daily volume of 618,500 shares, the days-to-cover ratio is currently 1.1 days.December 12, 2022 | marketbeat.comImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022December 12, 2022 | finance.yahoo.comImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022December 12, 2022 | finance.yahoo.comMerck Commences Tender Offer To Acquire Imago BioSciencesDecember 12, 2022 | markets.businessinsider.comHow Is The Market Feeling About Imago BioSciences?December 9, 2022 | msn.comImago BioSciences: The Bone Marrow Cancer Researcher Reaches MilestoneNovember 30, 2022 | seekingalpha.comImago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid LeukemiaNovember 30, 2022 | finance.yahoo.comHorizon Therapeutics Fields Takeover Interest From Pharma GiantsNovember 29, 2022 | finance.yahoo.comSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Imago BioSciences, Inc. - IMGONovember 29, 2022 | benzinga.comAnalyst Ratings for Imago BioSciencesNovember 28, 2022 | markets.businessinsider.comImago BioSciences (NASDAQ:IMGO) Lowered to Hold at Stifel NicolausNovember 28, 2022 | marketbeat.comPharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New IndicationNovember 25, 2022 | finance.yahoo.comImago Bio Shares Soar on Agreement to Selll to Merck for $1.35 Billion CashNovember 24, 2022 | 247wallst.comImago BioSciences, Inc. (NASDAQ:IMGO) Forecasted to Post Q2 2023 Earnings of ($0.63) Per ShareImago BioSciences, Inc. (NASDAQ:IMGO - Get Rating) - Equities researchers at Wedbush issued their Q2 2023 earnings per share (EPS) estimates for Imago BioSciences in a report issued on Monday, November 21st. Wedbush analyst R. Driscoll forecasts that the company will post earnings per share of ($November 24, 2022 | marketbeat.comImago BioSciences, Inc. Expected to Post Q1 2023 Earnings of ($0.57) Per Share (NASDAQ:IMGO)November 23, 2022 | marketbeat.comExpert Ratings for Imago BioSciencesNovember 22, 2022 | markets.businessinsider.comWhat 5 Analyst Ratings Have To Say About Imago BioSciencesNovember 22, 2022 | markets.businessinsider.comImago (IMGO) Shares Surge 104% on Buyout Offer From MerckNovember 22, 2022 | finance.yahoo.comImago BioSciences' (IMGO) "Neutral" Rating Reaffirmed at HC WainwrightNovember 22, 2022 | marketbeat.comMerck Eyes Expanded Blood Disorder Drug Pipeline Via $1.35 Billion Buyout of Imago BioSciencesNovember 21, 2022 | msn.comCancer-Focused Imago BioSciences Shares Soar After Merck DealNovember 21, 2022 | finance.yahoo.comImago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business UpdatesNovember 21, 2022 | ca.finance.yahoo.comMerck to Buy Imago, Shares GainNovember 21, 2022 | baystreet.caDisney, Imago BioSciences rise premarket; Coinbase, Carvana fallNovember 21, 2022 | msn.comImago BioSciences Shares Take Flight on Takeover by Merck >IMGONovember 21, 2022 | marketwatch.comIMGO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Imago BioSciences, Inc. Is Fair to ShareholdersNovember 21, 2022 | technews.tmcnet.comMerck to buy Imago Biosciences for $1.35 billionNovember 21, 2022 | finance.yahoo.comImago BioSciences Stock Surges. It’s Being Bought by Merck.November 21, 2022 | finance.yahoo.comImago BioSciences Catapults To Record High On Merck's $1.35 Billion BuyoutNovember 21, 2022 | finance.yahoo.comImago BioSciences, Inc. (NASDAQ:IMGO) Forecasted to Earn FY2022 Earnings of ($1.94) Per ShareImago BioSciences, Inc. (NASDAQ:IMGO - Get Rating) - Stock analysts at Jefferies Financial Group lowered their FY2022 EPS estimates for Imago BioSciences in a research report issued on Thursday, November 10th. Jefferies Financial Group analyst M. Raycroft now expects that the company will earn ($November 14, 2022 | marketbeat.comImago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business UpdatesNovember 9, 2022 | finance.yahoo.comAmy E. Tapper Sells 750 Shares of Imago BioSciences, Inc. (NASDAQ:IMGO) StockImago BioSciences, Inc. (NASDAQ:IMGO - Get Rating) insider Amy E. Tapper sold 750 shares of the business's stock in a transaction that occurred on Wednesday, November 2nd. The stock was sold at an average price of $17.90, for a total value of $13,425.00. Following the completion of the transaction, the insider now directly owns 119,047 shares in the company, valued at $2,130,941.30. The transaction was disclosed in a legal filing with the SEC, which is available at this link.November 4, 2022 | marketbeat.comImago BioSciences Announces Oral Data Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and ExpositionNovember 3, 2022 | finance.yahoo.com Get Imago BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IMGO and its competitors with MarketBeat's FREE daily newsletter. Email Address IMGO Media Mentions By Week IMGO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMGO News Sentiment▼0.000.59▲Average Medical News Sentiment IMGO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMGO Articles This Week▼00▲IMGO Articles Average Week Get Imago BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IMGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALKS News TGTX News AXSM News VRNA News OGN News PBH News BHVN News APLS News RARE News VKTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMGO) was last updated on 1/26/2025 by MarketBeat.com Staff From Our PartnersVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredThe #1 Stock for Trump’s Second Term?Imagine how much money you could make if you bought all of the top performing stocks during Trump's second ter...InvestorPlace | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imago BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imago BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
